Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...

These protein shells cross the blood-brain barrier [BBD] to provide therapeutic components ... Jr., said that third-party ...

Antibodies seek out and mark the diseased cells for destruction ... Early diagnosis is still the best weapon against cancer ...

Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...